These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14766368)

  • 41. Role of cholecystokinin in the control of food intake.
    Peikin SR
    Gastroenterol Clin North Am; 1989 Dec; 18(4):757-75. PubMed ID: 2693351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced CCK-induced Fos expression in the hindbrain, nodose ganglia, and enteric neurons of rats lacking CCK-1 receptors.
    Covasa M; Ritter RC
    Brain Res; 2005 Jul; 1051(1-2):155-63. PubMed ID: 16005445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecystokinin-8 inhibits methamphetamine-induced neurotoxicity via an anti-oxidative stress pathway.
    Wen D; An M; Gou H; Liu X; Liu L; Ma C; Cong B
    Neurotoxicology; 2016 Dec; 57():31-38. PubMed ID: 27565679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cholecystokinin and cholecystokinin receptor].
    Funakoshi A
    Nihon Rinsho; 1996 Apr; 54(4):1097-1103. PubMed ID: 8920681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
    Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
    J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats.
    Cano V; Ezquerra L; Ramos MP; Ruiz-Gayo M
    Br J Pharmacol; 2003 Nov; 140(5):964-70. PubMed ID: 14517181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Release of cholecystokinin in the central nervous system.
    Raiteri M; Paudice P; Vallebuona F
    Neurochem Int; 1993 Jun; 22(6):519-27. PubMed ID: 8513278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spinal heat shock protein (70) expression: effect of spinal ischemia, hyperthermia (42 degrees C)/hypothermia (27 degrees C), NMDA receptor activation and potassium evoked depolarization on the induction.
    Sasara T; Cizkova D; Mestril R; Galik J; Sugahara K; Marsala M
    Neurochem Int; 2004 Jan; 44(1):53-64. PubMed ID: 12963088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence.
    Ballaz SJ; Akil H; Watson SJ
    Neurosci Lett; 2007 Nov; 428(1):27-32. PubMed ID: 17950531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen modulation of opioid and cholecystokinin systems in the limbic-hypothalamic circuit.
    Micevych PE; Eckersell CB; Brecha N; Holland KL
    Brain Res Bull; 1997; 44(4):335-43. PubMed ID: 9370197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
    Tortorici V; Nogueira L; Salas R; Vanegas H
    Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
    Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA
    Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cholecystokinins and their receptors. Functional aspects].
    Böhme GA; Blanchard JC
    Therapie; 1992 Nov; 47(6):541-8. PubMed ID: 1301646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide pools.
    Crawley JN
    Peptides; 1985; 6 Suppl 2():129-36. PubMed ID: 3001671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for a role of cholecystokinin as neurotransmitter in the guinea-pig enteric nervous system.
    Schutte IW; Hollestein KB; Akkermans LM; Kroese AB
    Neurosci Lett; 1997 Nov; 236(3):155-8. PubMed ID: 9406760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
    Guan D; Rivard N; Maouyo D; Gettys TW; Morisset J
    Regul Pept; 1993 Feb; 43(3):169-76. PubMed ID: 8441822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
    Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
    Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholecystokinin and its receptors in vertebrates and invertebrates.
    Vigna SR
    Peptides; 1985; 6 Suppl 3():283-7. PubMed ID: 3008121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central leptin and cholecystokinin in gastroprotection against ethanol-induced damage.
    Brzozowski T; Konturek PC; Konturek SJ; Pierzchalski P; Bielanski W; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG
    Digestion; 2000; 62(2-3):126-42. PubMed ID: 11025360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.
    Reidelberger RD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1354-8. PubMed ID: 1481948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.